These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 7609774)

  • 21. SR 57227A: a potent and selective agonist at central and peripheral 5-HT3 receptors in vitro and in vivo.
    Bachy A; Héaulme M; Giudice A; Michaud JC; Lefevre IA; Souilhac J; Manara L; Emerit MB; Gozlan H; Hamon M
    Eur J Pharmacol; 1993 Jun; 237(2-3):299-309. PubMed ID: 7689975
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution and characterisation of [3H]alpha,beta-methylene ATP binding sites in the rat.
    Michel AD; Humphrey PP
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Dec; 348(6):608-17. PubMed ID: 8133903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Specific labelling of serotonin 5-HT(1B) receptors in rat frontal cortex with the novel, phenylpiperazine derivative, [3H]GR125,743. A pharmacological characterization.
    Millan MJ; Newman-Tancredi A; Lochon S; Touzard M; Aubry S; Audinot V
    Pharmacol Biochem Behav; 2002 Apr; 71(4):589-98. PubMed ID: 11888550
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The interaction of trichloroethanol with murine recombinant 5-HT3 receptors.
    Downie DL; Hope AG; Belelli D; Lambert JJ; Peters JA; Bentley KR; Steward LJ; Chen CY; Barnes NM
    Br J Pharmacol; 1995 Apr; 114(8):1641-51. PubMed ID: 7541281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of (S)-des-4-amino-3-[125I]iodozacopride ([125I]DAIZAC), a selective high-affinity radioligand for 5-hydroxytryptamine3 receptors.
    Hewlett WA; Trivedi BL; Zhang ZJ; de Paulis T; Schmidt DE; Lovinger DM; Ansari MS; Ebert MH
    J Pharmacol Exp Ther; 1999 Jan; 288(1):221-31. PubMed ID: 9862774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autoradiographic distribution of [3H]-(S)-zacopride-labelled 5-HT3 receptors in human brain.
    Parker RM; Barnes JM; Ge J; Barber PC; Barnes NM
    J Neurol Sci; 1996 Dec; 144(1-2):119-27. PubMed ID: 8994113
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Labelling of 5-hydroxytryptamine3 receptors with a novel 5-HT3 receptor ligand, [3H]RS-42358-197.
    Wong EH; Bonhaus DW; Wu I; Stefanich E; Eglen RM
    J Neurochem; 1993 Mar; 60(3):921-30. PubMed ID: 8436978
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide.
    Steward LJ; West KE; Kilpatrick GJ; Barnes NM
    Eur J Pharmacol; 1993 Oct; 243(1):13-8. PubMed ID: 8253120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [3H]-thioperamide as a radioligand for the histamine H3 receptor in rat cerebral cortex.
    Alves-Rodrigues A; Leurs R; Wu TS; Prell GD; Foged C; Timmerman H
    Br J Pharmacol; 1996 Aug; 118(8):2045-52. PubMed ID: 8864541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct thermodynamic parameters of serotonin 5-HT3 agonists and antagonists to displace [3H]granisetron binding.
    Maksay G
    J Neurochem; 1996 Jul; 67(1):407-12. PubMed ID: 8667020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]-Mesulergine labels 5-HT7 sites in rat brain and guinea-pig ileum but not rat jejunum.
    Hemedah M; Coupar IM; Mitchelson FJ
    Br J Pharmacol; 1999 Jan; 126(1):179-88. PubMed ID: 10051134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterisation of 5-HT3 recognition sites in membranes of NG 108-15 neuroblastoma-glioma cells with [3H]ICS 205-930.
    Neijt HC; Karpf A; Schoeffter P; Engel G; Hoyer D
    Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):493-9. PubMed ID: 3412489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors.
    Lyon RA; Davis KH; Titeler M
    Mol Pharmacol; 1987 Feb; 31(2):194-9. PubMed ID: 3543649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
    Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
    Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [3H]zacopride: ligand for the identification of 5-HT3 recognition sites.
    Barnes NM; Costall B; Naylor RJ
    J Pharm Pharmacol; 1988 Aug; 40(8):548-51. PubMed ID: 2907008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of [3H]YM060, a potent and selective 5-HT3 receptor radioligand, in the cerebral cortex of rats.
    Akuzawa S; Miyata K; Fukutomi H
    Eur J Pharmacol; 1995 Jul; 281(1):37-42. PubMed ID: 8566114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.
    Khawaja X; Ennis C; Minchin MC
    Life Sci; 1997; 60(9):653-65. PubMed ID: 9048968
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Characterization of [3H]meta-chlorophenylbiguanide binding to 5-HT3 receptors in N1E-115 neuroblastoma cells.
    Lummis SC; Sepúlveda MI; Kilpatrick GJ; Baker J
    Eur J Pharmacol; 1993 Oct; 243(1):7-11. PubMed ID: 8253126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantitative autoradiographic characterisation of the binding of [3H]WAY-100635, a selective 5-HT1A receptor antagonist.
    Khawaja X
    Brain Res; 1995 Mar; 673(2):217-25. PubMed ID: 7606435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allosteric interactions among agonists and antagonists at 5-hydroxytryptamine3 receptors.
    Bonhaus DW; Stefanich E; Loury DN; Hsu SA; Eglen RM; Wong EH
    J Neurochem; 1995 Jul; 65(1):104-10. PubMed ID: 7790853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.